menu
    • menu

    Company profile for Gadeta

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Gadeta is a clinical stage biotechnology company developing a first-in-class cellular immunotherapy for the treatment of cancer, using a number of proprietary T-cell engineering and manufacturing technologies.We are using a number of proprietary T-cell engineering and manufacturing technologies. We are pioneering the development of αβ T-cells engineered to express defined γδ T-cell receptors that can specifically recognize...
    Gadeta is a clinical stage biotechnology company developing a first-in-class cellular immunotherapy for the treatment of cancer, using a number of proprietary T-cell engineering and manufacturing technologies.We are using a number of proprietary T-cell engineering and manufacturing technologies. We are pioneering the development of αβ T-cells engineered to express defined γδ T-cell receptors that can specifically recognize cancer cells Gadeta uses the unique characteristics of γδ T cell receptors (TCRs) in the broad recognition of both haematological and solid tumour cells and their potential use treatment of advanced malignancies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GadetaNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Yalelaan 62 3584 CM Utrecht
    Telephone
    Telephone
    +31 (0) 85 016 44 66
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gadeta.nl/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gadeta/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
    Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4

    03 Dec 2022

    // NASDAQ

    https://www.nasdaq.com/press-release/immunocore-and-gadeta-announce-agreement-to-develop-first-gamma-delta-gd-tcr-immtac

    NASDAQ
    03 Dec 2022
    Share Share
    Gadeta Appoints Scientific Advisory Board and Provides Business Update
    Gadeta Appoints Scientific Advisory Board and Provides Business Update

    20 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gadeta-appoints-scientific-advisory-board-and-provides-business-update-301654707.html

    PRNEWSWIRE
    20 Oct 2022
    Share Share
    Gadeta to Present Data on Tumor-Specific Cell Therapies
    Gadeta to Present Data on Tumor-Specific Cell Therapies

    28 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gadeta-to-present-data-on-tumor-specific-cell-therapies-at-leading-scientific-conferences-301510979.html

    PRNEWSWIRE
    28 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search